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ABSTRACT
Objectives To study the duration of depression, recovery
over time, and predictors of prognosis in an older cohort
(≥55 years) in primary care.
DesignLongitudinalcohortstudy,withthreeyears’follow-
up.
Setting 32 general practices in West Friesland, the
Netherlands.
Participants 234 patients aged 55 years or more with a
prevalent major depressive disorder.
Main outcome measures Depression at baseline and
every six months using structured diagnostic interviews
(primary care evaluation of mental disorders according to
diagnoses in Diagnostic and Statistical Manual of Mental
Disorders, fourth edition) and a measure of severity of
symptoms (Montgomery Åsberg depression rating scale).
Themainoutcomemeasuresweretimetorecoveryandthe
likelihood of recovery at different time points.
Multivariable analyses were used to identify variables
predicting prognosis.
Results The median duration of a major depressive
episode was 18.0 months (95% confidence interval 12.8
to23.1).35%ofdepressedpatientsrecoveredwithinone
year,60%withintwoyears,and68%withinthreeyears.A
pooroutcome was associated withseverity of depression
at baseline, a family history of depression, and poorer
physical functioning. During follow-up functional status
remained limited in patients with chronic depression but
not in those who had recovered.
Conclusion Depression among patients aged 55 years or
more in primary care has a poor prognosis. Using readily
available prognostic factors (for example, severity of the
index episode, a family history of depression, and
functionaldecline)couldhelpdirecttreatmenttothoseat
highest risk of a poor prognosis.
INTRODUCTION
At all ages depression is a common and disabling
condition. Although physical disorders and dementia
increase noticeably with age, both the prevalence and
the consequences of depressive disorders retain an
enormous impact on the health of ageing populations.
Theeffectsofdepressionarewelldocumentedondaily
functioning; wellbeing
1; the onset and prognosis of
chronic physical illnesses such as cardiovascular
disorders
2 and diabetes
3; mortality
4; and utilisation of
health services.
5 Although the importance of depres-
sion in later life is widely acknowledged and recent
trials have shown convincingly that treatment can be
effective
67 depression in most older patients remains
undiagnosed and therefore untreated.
8-10 Given the
increase in the ageing population, it is unlikely that
evenhealthserviceswithgoodresourceswillbeableto
provide treatment for all older patients with depres-
sion. It is therefore important to be able to predict the
outcome and to identify those patients most at risk of a
poor outcome such as chronicity. As most older
depressed patients contact their general practitioner,
themostrelevantdataonprognosisareinthesettingof
primary care.
11
Although several studies on prognosis are available,
fewhavebeendoneinprimarycare,includedsufficient
numbers for analyses, had access to adequate diag-
nostic data at baseline and follow-up, or tested the
impact of prognostic factors, while using enough
observations to be able to model the variability in the
prognosisofamajordepressivedisorder.
12Westudied
a group of older patients with depression in primary
care over three years to provide accurate estimates of
the duration of depressive episodes, the likelihood of
recovery over time, and predictors of the prognosis.
METHODS
The West Friesland Study is a cohort study on
depression in later life (≥55 years) in primary care,
with follow-up for three years. We recruited general
practitionersinWestFriesland,aruralareainthenorth
west of the Netherlands. Thirty four general practi-
tioners from 32 practices provided patients for the
study.
From June 2000 to December 2002 we used a two
stage screening procedure to recruit potential partici-
pants with a prevalent major depressive disorder. This
method is described in detail elsewhere.
13 Briefly,
consecutive patients aged 55 or more visiting their
general practitioner were invited to fill in the geriatric
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1415 regardless of the reason
forconsultation.Patientswithascoreabovethecut-off
of 5 were invited for a diagnostic interview using the
primary care evaluation of mental disorders,
16 which
was carried out by trained interviewers within 14 days
of the depression scale having been completed. By
using this method we were able to include the whole
spectrum of patients with depression seen in general
practice, from new cases to patients with depression
who were receiving long term treatment. We inter-
viewed participants every six months for three years.
Written informed consent was obtained.
Depression
Amajordepressivedisorderaccordingtocriteriafrom
the Diagnostic and Statistical Manual of Mental Disorders,
fourth edition, was diagnosed using the primary care
evaluation of mental disorders (range 0-9).
16 This
instrument comprises nine items for depression and
was designed for diagnosing major depressive dis-
ordersinprimarycaresettingsforclinicalandresearch
use. It is easy to use in daily practice and is
recommended by the Dutch College of General
Practitioners.
17
We assessed the course of depression every six
months using the primary care evaluation of mental
disorders and the Montgomery Åsberg depression
rating scale (range 0-60),
18 a higher score indicating
more severe depression. This scale was designed to
measure the severity of depression. A cut-off of 10
defines recovery from depressive symptoms.
19 In the
present study we defined recovery as the patient no
longer fulfilling the diagnostic criteria for major
depressive disorders and having a score of less than
10ontheMontgomeryÅsbergdepressionratingscale.
Potential predictors of prognosis
We used structured questionnaires at baseline and at
one, two, and three years to collect information on
personal characteristics, including age, sex, living
situation,yearsofeducation,comorbidphysicalillness,
and use of medication. The questionnaire for chronic
somaticcomorbiditycontainsalistofsomaticdiseases:
pulmonary disease (asthma, chronic obstructive pul-
monary disease, chronic bronchitis), cardiovascular
diseases,peripheralarterialdiseases,diabetesmellitus,
cerebrovasculardiseases,osteoarthritis,otherarthritis,
or malignancies.
20 We chose the cut-off of none versus
one versus more than one disease to produce
subgroups of patients with more or less comorbidity.
We used the mini-mental status examination to
measure cognitive decline annually.
21 A cut-off of 24
definescognitiveimpairment.
22Comorbidanxietywas
assessedusingtheanxietyquestionnaireoftheprimary
care evaluation of mental disorders, which inquires
about panic attacks in the past month.
16 We used the
diagnostic interview schedule
23 to assess the age at
onset of the first depressive episode, family history of
depression, and the number of previous episodes of
depression. Early onset depression was defined as a
first depressive episode before age 55. We categorised
the number of previous episodes as none versus one
versusmorethanonetoproducesubgroupsofpatients
with a history of depression. Finally, we ascertained
physical functioning annually using the physical
component scale of the medical outcome study 36-
items, short form (range 0-100),
2425 a higher score
indicating better physical functioning.
Statistical analysis
Dropouts
When appropriate we used independent t tests or χ
2
tests to compare the baseline characteristics of partici-
pantswithonlyabaselinemeasurementwiththosewho
had measurements at follow-up. To explore the
characteristics of dropouts we compared participants
whohadfewerthanfourmeasurementswiththosewho
had four or more.
Duration of depressive episodes and likelihood of recovery
over time
We analysed the duration of the episodes of major
depressive disorders using time to recovery as the
outcomemeasure.Timetorecoveryandthelikelihood
of recovery at different time points were estimated
using Kaplan Meier methods. For these analyses we
included patients with at least one follow-up measure-
ment.
Potential predictors of outcome
We used Cox regression analyses to identify determi-
nantsatbaselinepredictingpooroutcome(norecovery
during follow-up). Firstly, we investigated whether
there was a linear relation between the potential
predictor variables and the outcome. We divided
thosevariableswithnon-linearrelationsintocategories
(two or three), using cut-off scores described in the
literature or using the median of the sum score.
Secondly, we carried out univariable regression
analyses for all potential predictors with the outcome
measure. For the multivariable analyses we selected
variables that might be associated with the outcome
(P<0.20). Thirdly, we entered the predictors simulta-
neously in a multivariable regression model. We
Patients completing geriatric depression scale -15 items (n=4222)
More than two missing answers (n=37)
Score >5 (n=659)
Completed primary care evaluation of mental disorders (n=458)
Major depressive disorder present (n=244)
Refused diagnostic interview (n=201)
Included in study (n=234)
Refused to participate (n=10)
Fig 1 | Flow of respondents through study
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backward selection method. We deleted the variables
with the lowest predictive value (the largest P value in
the multivariable model). The best fitting model was
tested with the log likelihood ratio test (P<0.10). All
analyses were carried out using SPSS version 15.0.
Besides the predictors at baseline we also explored
changes in these variables during follow-up using data
from the annual measurements. We compared the
resultsofthose whohadrecoveredwith thosewhostill
had depression. We used the same cohort as that for
Cox survival analyses—that is, patients with a major
depressive disorder at baseline and at least one follow-
up measurement.
RESULTS
Figure 1 shows the flow of respondents through the
study.Overall,4222of5395(78.3%)patientswhowere
invited to fill in the geriatric depression scale com-
pleted the questionnaire. Non-responders were more
often men and of similar age. Thirty seven responders
(0.9%) were excluded because they had missed more
thantwoanswersonthedepressionscale.Ofthosewho
completed the questionnaire, 659 (16%) scored above
the cut-off of 5. Of these, 458 (70%) gave informed
consent for a diagnostic interview using the primary
care evaluation of mental disorders. Responders and
non-responderswere not significantlydifferent for age
(mean difference 1.0 year, 95% confidence interval
−0.5 to 2.6; P=0.175), sex (odds ratio 1.0, 95%
confidence interval 0.7 to 1.4; P=0.822), or depression
score (mean difference 0.13, −0.6 to 0.3; P=0.658).
Of the 458 patients who took part in the diagnostic
interview, 244 (53%) fulfilled the criteria for a major
depressive disorder of whom 234 (96%) agreed to
participateinthebaselineinterview.Table 1showsthe
characteristics of the cohort. Participants who missed
an assessment were invited to successive ones.
Dropouts
Two hundred and four participants (87%) had at least
onefollow-upmeasurementandwereanalysed.Thirty
had only completed the baseline interview. They were
older than those with follow-up measurements (mean
difference 4.1 years, 0.8 to 7.4; P=0.04), but were not
significantlydifferentforsex(oddsratio1.1,0.5to2.5;
P=0.77), level of education (low v middle v high;
P=0.87), categories of comorbidity (none v one v more
than one; P=0.37), living alone or with others (odds
ratio 0.7, 0.3 to 1.7; P=0.52), or baseline depression
score (mean difference 0.4, −0.1 to 0.9; P=0.10).
Overall, 175 respondents (75%) completed four or
moreofthesevenassessmentsduringfollow-up.Those
with fewer than four measurements were older (mean
difference4.6years,2.1to7.1;P<0.01)andhadalower
level of education (P=0.04) but were not different for
sex (odds ratio 0.6, 0.3 to 1.1; P=0.07), categories of
comorbidity(P=0.25),livingaloneorwithothers(odds
ratio 1.2, 0.6 to 2.2; P=0.60), or baseline depression
score (mean difference 0.2, −0.2 to 0.5; P=0.44).
Duration of depressive episodes and likelihood of
recovery over time
Figure2showstheKaplanMeiercurveforrecoveryin
the 204 participants with at least one follow-up
measurement. The mean time to recovery was
19.3 months (95% confidence interval 17.5 to 21.2),
andthemediantimetorecoverywas18.0months(12.8
to 23.1). Overall, 35.1% (95% confidence interval
28.3% to 42.0%) of participants had recovered at one
year, 60.4% (53.0% to 67.7%) at two years, and 68.1%
(60.9% to 75.3%) at three years.
Predictors of prognosis
Univariable Cox survival analysis showed that eight
variables were associated with time to recovery
(P<0.20; table 2). As the Montgomery Åsberg
depression rating scale and primary care evaluation
of mental disorders were both associated with the
Table 1 |Baseline characteristics of cohort of older depressed
patients (n=234) in primary care, the Netherlands. Values are
numbers (percentages) unless stated otherwise
Characteristics
Patients with major
depressive disorder
(n=234)
Age (years):
55-64 115 (49)
65-74 73 (31)
≥75 46 (20)
Women 146 (62)
Educational level (years):
Low (0-6) 73 (31)
Middle (7-10) 146 (62)
High (>10) 15 (6)
Living alone 87 (37)
Depression:
Mean (SD) MÅDRS score (0-60) 19.6 (7.8)
Mean (SD) PRIME-MD score (0-9) 6.6 (1.3)
Depression in family 67 (29)
Previous depressive episodes:
0 22 (10.2)
1 41 (19.0)
≥1 153 (70.8)*
Early onset depression (<55 years) 148 (63)
Other:
Mean (SD) MMSE score 26.7 (2.8)
Anxiety 76 (33)
Chronic illness:
0 30 (13)
1 66 (28)
≥1 138 (59)
Mean (SD) functional limitations (0-100) 40.8 (13.2)
Treatment for depression:
None 141 (60)
Antidepressants 72 (31)
Referral 21 (9)
MÅDRS=Montgomery Åsberg depression rating scale; PRIME-MD=primary
care evaluation of mental disorders; MMSE=mini-mental state
examination.
*Answers missing for 17 cases.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 7prognosis but were also highly correlated (Pearson’sr
0.5), only the scores on the primary care evaluation of
mental disorders were used for the multivariable
analyses as an indicator for severity of depression at
baseline. In the best fitting multivariable model poor
outcomewasassociatedwithmoreseveredepressionat
baseline (primary care evaluation of mental disorders,
range 0-9; hazard ratio 1.25, 95% confidence interval
1.08 to 1.45), a family history of depression (1.45, 0.97
to 2.17), and less physical functioning (0.98, 0.97 to
0.99).
Only 40% of the patients with depression were
receiving treatment for depression at baseline—31%
were taking antidepressants and 9% were referred to
specialisedmentalhealthcare(table 1).Noassociation
was found between treatment for depression
(antidepressants or referral) and recovery. Patients
receivingtreatment,however,hadmoreseveredepres-
sion at baseline (mean difference in score on Mont-
gomery Åsberg depression rating scale 4.5; P<0.01).
Cognitive decline did not change during follow-up,
and no difference was found between those who still
haddepressionandthosewhohadrecovered(table 3).
Only one patient dropped out during follow-up owing
to serious cognitive decline and missed the last
interview at three years. The prevalence of chronic
diseasesincreasedovertimeandwasmorecommonin
the depressed group than in the recovered group. The
depressedgroupshowedadeclineindailyfunctioning,
butthisdidnotseemtochangeintherecoveredgroup.
Finally, the number of patients receiving treatment for
depression hardly changed during follow-up. At three
years,only37%ofpatientswerebeingtreatedfortheir
depression, compared with 24% in the recovered
group.Onlyafewpatientsinbothgroupswerereferred
to specialised mental health care, indicating that
treatment for depression in late life is mainly carried
out in primary care.
DISCUSSION
The prognosis for depression among older patients
(≥55 years) in primary care is poor. The median
durationofamajordepressiveepisodewas18months.
Thirty five per cent had recovered within one year,
60% after two years, and 68% at three years.
A systematic review on the prognosis of depression
in later life reported a poorer outcome in inpatients;
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Fig 2 | Survival curve of 204 patients aged 55 years or more
with major depressive disorder in primary care
Table 2 |Univariable and multivariable Cox survival analyses for potential predictors of no recovery from major depressive
disorder (n=204), measured at baseline, with follow-up for three years
Characteristics
Univariable Multivariable
Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Age (years)* 1.02 (1.00 to 1.04) 0.143 ——
Sex (women v men) 1.06 (0.75 to 1.52) 0.729 ——
Education: 0.325 ——
Middle v low 1.28 (0.88 to 1.89) 0.185 ——
High v low 0.95 (0.49 to 1.85) 0.878 ——
Living alone (yes v no)* 1.32 (0.91 to 1.89) 0.145 ——
Comorbidity (somatic or psychiatric):
Chronic somatic diseases — 0.408 ——
1 v 0 1.22 (0.72 to 2.04) 0.463 ——
≥1 v 0 1.39 (0.85 to 2.27) 0.191 ——
Anxiety (yes v no)* 1.28 (0.88 to 1.85) 0.184 ——
Cognitive dysfunction, MMSE score
≥24 v <24
1.35 (0.79 to 2.27) 0.270 ——
Depression:
MÅDRS score (0-60)*† 1.05 (1.03 to 1.08) <0.001 ——
PRIME-MD score (0-9)* 1.22 (1.06 to 1.41) <0.001 1.25 (1.08 to 1.45) 0.003
Family history (yes v no)* 1.30 (0.88 to 1.92) 0.185 1.45 (0.97 to 2.17) 0.070
Early onset (<55 years)* 1.30 (0.90 to 1.89) 0.158 ——
Treatment (yes v no) 1.10 (0.77 to 1.57) 0.617 ——
Quality of life, PCS (0-100)* 0.99 (0.98 to 1.00) 0.055 0.98 (0.97 to 0.99) 0.008
MMSE=mini-mental state examination score; MÅDRS=Montgomery Åsberg depression rating scale; PRIME-MD=primary care evaluation of mental
disorders; PCS=physical component scale of SF-36.
*P<0.20. These eight variables were associated with poor outcome in univariable analyses and therefore selected for multivariable analysis.
†MÅDRS and PRIME-MD were highly correlated. Therefore only PRIME-MD was used for the multivariable model.
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with 35% in our study.
26 The researchers studied the
prognosisofolderpatientswhowereadmittedfromthe
emergency room to medical services. A possible
explanation for the difference is the higher prevalence
of functional limitations among inpatients, which was
also a predictor of poor clinical outcome in our study.
The systematic review showed a better clinical out-
come in hospital based studies. This might be due to
betteradherencetotreatment.
27Inourcohortonly40%
of patients with a major depressive disorder were
receiving treatment at baseline. This is less than the
45% found in the Netherlands Mental Health Survey
and Incidence Study of adults with depression in the
community,
28 suggesting that a worse prognosis in
older patients might be partly due to less adequate
treatments.
Predictors of prognosis
Poor outcome was associated with the severity of the
index episode, a family history of depression, and
functional decline. Previous community studies on
depression in later life also found evidence of an
association between these variables and the prognosis
for depression.
12 These clinical factors are all available
in routine practice and could therefore be used to help
decide on the aggressiveness of treatment. Our data
showed that functional limitations increased over the
three years of follow-up in the group with chronic
depression but not in those who had recovered. This
finding agrees with those of another study
29 and
underlines the importance of chronic depression as a
disabling illness. More research is needed on this
longitudinal association.
Whether there is an association between depression
in later life and cognitive decline is debatable. Some
researchershave found evidence foran association
30-32
and others not.
33-35 The present study did not provide
evidenceeitheratbaseline(table 2)orduringfollow-up
(table 3).
Only a small proportion of patients with depression
were being treated at baseline and during follow-up.
This was also found in previous studies.
2936 We found
no association between treatment for depression and
the prognosis. Patients who were receiving treatment,
however, had more severe depression at baseline
(mean difference in score on Montgomery Åsberg
depressionratingscale4.5),suggestingconfoundingby
indication.
Itislikelythattheprognosisofdepressioninlaterlife
is determined by many factors, at least some of which
are inter-related. Therefore any definitive statement
about causal inference or confounding would be
premature. We provided data on factors that predict
the prognosis, controlling for their inter-relatedness.
This is highly relevant for clinical practice, as it
identifies those with the highest risk of a poor
prognosis.
Strengths and limitations
We used both diagnostic and dimensional data
ascertained at multiple time points during follow-up
to study the course of major depressive disorder in a
large cohort of older patients in primary care. These
strengths, together with follow-up for three years and
access to several putative prognostic factors, allowed a
thorough assessment of the prognosis of depression in
later life.
Our study did, however, have some limitations. We
included a sample of older patients with depression in
daytodayclinicalpractice,andconsequentlyincluded
those with existing depression. As depression has a
variableprognosis,thissamplingstrategymayhaveled
to over-representation of patients with persistent long
term depression. The alternative strategy would have
been to include patients without depression and to
follow them up, concentrating on those with incident
depression. However, this was precluded because of
the large sample that would be needed at baseline and
Table 3 |Longitudinal data on cohort of older (≥55 years) depressed patients compared with
recovered patients with at least one measurement at follow-up, the Netherlands. Values are
numbers (percentages) unless stated otherwise
Characteristic
Baseline
(n=204) 1 year (n=185) 2 years (n=169) 3 years (n=160)
Major depressive disorder 204 (100) 120 (65) 67 (40) 51 (32)
Recovered 0 65 (35) 102 (60) 109 (68)
Mean (SD) MÅDRS (0-60) score:
Major depressive disorder 19.3 (7.9) 15.1 (7.6) 17.8 (8.0) 17.5 (7.1)
Recovered — 6.4 (4.2) 7.9 (6.1) 8.6 (6.2)
Anxiety:
Major depressive disorder 68 (33) 17 (14) 13 (19) 9 (18)
Recovered — 6 (9) 6 (5) 13 (12)
Mean (SD) MMSE score:
Major depressive disorder 26.9 (2.6) 27.1 (2.7) 27.3 (2.6) 27.3 (2.2)
Recovered — 27.7 (1.9) 27.8 (2.2) 27.2 (2.3)
Chronic illness
Major depressive disorder:
0 28 (14) 23 (19) 11 (16) 7 (14)
1 59 (29) 34 (28) 17 (26) 12 (23)
≥1 117 (57) 63 (53) 39 (58) 32 (63)
Recovered:
0 — 18 (28) 15 (15) 26 (24)
1 — 20 (31) 33 (32) 24 (22)
≥1 — 27 (41) 54 (53) 59 (54)
Mean (SD) functional limitations (0-100)
Major depressive disorder 41.7 (13.1) 40.3 (12.0) 37.8 (12.5) 37.2 (12.0)
Recovered — 44.0 (12.6) 42.1 (11.3) 43.0 (12.1)
Treatment for depression
Major depressive disorder:
None 126 (62) 84 (70) 45 (67) 32 (63)
Antidepressants 61 (30) 26 (22) 19 (28) 17 (33)
Referral 17 (8) 10 (8) 3 (5) 2 (4)
Recovered:
None — 46 (71) 79 (77) 83 (76)
Antidepressants — 13 (20) 20 (20) 21 (19)
Referral — 6( 9 ) 2( 3 ) 5( 5 )
Deaths — 2( 1 ) 4( 2 ) 9( 4 )
MÅDRS=Montgomery Åsberg depression rating scale; MMSE=mini-mental state examination.
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cohort.Thepresentresultsaregeneraliseabletoacross
section of patients with depression, as the condition is
present at any time in general practice, but might
overestimate chronicity because of the sampling of
prevalent cases.
Wescreenedconsecutivepatientsaged55yearsand
older whovisited their doctor,regardless of the reason
forconsultation.Asthesepatientswereabletocometo
the practice and 98% were living independently, they
were a selection of the more healthy older population.
Furthermore, those lost to the analyses throughout the
studywereolder.Althoughagewasnotassociatedwith
prognosis (table 2), it can be assumed that older
patients might be frailer and more at risk of functional
limitations. Given that functional limitations are a
predictorforpoorclinicaloutcome,ourresultsmaybe
an underestimation of the true course of depression
owing to attrition of the frailest patients during follow-
up.
We assessed prognosis every six months. Using an
intervalofsixmonthstoassesspatientsmayhaveledto
an overestimation of the duration of depression
because patients might have recovered earlier. We
didnot,however,haveaccesstodataonthedurationof
the index episode at inclusion. This has the effect of
systematically underestimating the true duration of
episodesandcounteractsthe potentialoverestimation.
TheadvantageofCoxsurvivalanalysesisthatweused
dataonrespondentswithmorethanonemeasurement.
However,inthoserespondentswhomissedinterviews,
either the follow-up was less than three years or the
interval between measurements was more than six
months, which may have led to bias. For example, the
interval between assessments for a respondent who
missedthethirdassessmentwas12months.Duringthis
period the patient could have recovered, leading to a
potential overestimation of time to recovery. Those
withfewerthanfourmeasurementswereolderandhad
a lower level of education than those with more
measurements. Both variables were not associated
with the outcome.
Our design was observational, providing an insight
into the clinical course of depression without inter-
vening with structured treatment protocols. This
makes the results representative of the population
seenbygeneralpractitioners.Assumingthattreatment
is not harmful to most patients, the effect of our
naturalistic design would be to underestimate the true
clinical course of depression among older patients.
Weonlyhadaccesstoselfreporteddataontreatment
fordepression.Itispossiblethatthedoctorsprescribed
more antidepressants or referred more patients to
specialised mental health care than was reported,
owingtonon-adherenceofthepatients.Theadvantage
of self reporting treatment is that we are more likely to
have collected data on actual treatment received by
patients.
Conclusion
Our results support our hypothesis that the prognosis
of depression in later life in primary care would be
poor. One possible explanation for this is inadequate
treatment in older patients with depression, as most
(60% of patients with major depressive disorder at
baseline,71-77%duringfollow-up)didnotreceiveany
treatment for their condition. Analyses of data on
patients with undetected depression during the first
yearoffollow-upshowedapoorprognosis;depression
was still present in 67% of these patients after one
year.
10Identifyingpatientswithdepressionathighrisk
of a poor outcome can help to improve treatment and
therefore prognosis. We found that a poor outcome
was predicted by clinical factors that should be readily
available in routine practice. If confirmed in other
studies, these factors could be incorporated in profes-
sional guidelines, helping clinicians to identify older
patients needing earlier, better integrated, and more
aggressive treatment. Finally, research is needed to
learn more about the longitudinalassociation between
depression and functional limitations.
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